|
John Brandsema, MD
(Children's Hospital of Philadelphia, Division of Neurology)
|
Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta. Dr. Brandsema has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Brandsema has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dyne. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Scholar Rock. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edgewise. Dr. Brandsema has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for CureSMA. The institution of Dr. Brandsema has received research support from Novartis. The institution of Dr. Brandsema has received research support from Biogen. The institution of Dr. Brandsema has received research support from Alexion. The institution of Dr. Brandsema has received research support from CSL Behring. The institution of Dr. Brandsema has received research support from Pfizer. The institution of Dr. Brandsema has received research support from PTC Therapeutics. The institution of Dr. Brandsema has received research support from Sarepta. The institution of Dr. Brandsema has received research support from Astellas. The institution of Dr. Brandsema has received research support from Fibrogen. The institution of Dr. Brandsema has received research support from Genentech. The institution of Dr. Brandsema has received research support from Janssen. The institution of Dr. Brandsema has received research support from Scholar Rock. |
|
Cecil D. Hahn, MD
(The Hospital for Sick Children)
|
Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda Pharmaceuticals. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Holberg EEG. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pendopharm. Dr. Hahn has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for various legal firms. Dr. Hahn has received publishing royalties from a publication relating to health care. Dr. Hahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with CADTH. |